Information webinar: Prescribing COVID-19 anti-viral medications

With the arrival of the new COVID-19 anti-viral medications in BC, there are a number of requirements doctors need to know when it comes to prescribing Paxlovid and Sotrovimab including the treatment window for each, dosage protocols, how they contradict or interact with other medications, etc.

Currently BC has received 4,000 doses of Paxolovid, with an additional 4,000 due this month and another 12,000 in March. The COVID-19 Therapeutics Committee (CTC) has been working on conditional recommendations for tiers of patients most likely to benefit from this medication, which is used in mild to moderately ill patients to shorten the course and severity of illness, and decrease the probability of hospitalization.

Please join Doctors of BC, in partnership with the Provincial Health Services Authority, on Wednesday, February 9th from 6:00pm – 7:00pm for an information webinar on prescribing these anti-viral medications. Speakers will include:

• Maureen O’Donnell,  Executive Vice President, Clinical Policy, Planning and Partnerships, Provincial Health Services Authority, who will discuss the approach for “waves” of prescribers
• Jolanta Piszczek, Chair, BC COVID-19 Therapeutics Committee (CTC) and UBC Clinical Associate Professor, who will highlight the CTC recommendations and evidence
• Eric Partlow, Clinical Instructor, UBC Department of Infectious Disease and Jennifer Grant, Medical Microbiologist, Vancouver Coastal Health who will highlight real-world experiences identifying patients and prescribing Paxlovid

To register for the Zoom webinar, please click here.

If you are unable to participate, the session will be recorded and the video will be posted to our COVID-19 webpage as soon as it’s available.

Should you have any questions, please contract View Email Addresscommunications@doctorsofbc.ca.